AFP and hepatocellular carcinoma: In our study, the methylation of FBXO43 promoter in PBMCs showed high sensitivity in diagnosing HBV-associated HCC (76.42%), with a larger AUC than for AFP serum level (0.793 vs. 0.780), and better diagnostic performance and higher clinical application value when combined with AFP serum level.